Axicabtagene-ciloleucel/ipilimumab/nivolumabVarious toxicities: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1854卷 / 1期

关键词：

D O I：

10.1007/s40278-021-95402-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：71 / 71

相关论文

共 50 条

[1] Axicabtagene-ciloleucel/tisagenlecleucelVarious toxicities and lack of efficacy: 12 case reports
Reactions Weekly, 2024, 2035 (1) : 93 - 93
[2] Axicabtagene-ciloleucel/cyclophosphamide/tisagenlecleucelHaematological toxicities and cytokine release syndrome: 2 case reports
Reactions Weekly, 2021, 1866 (1) : 77 - 77
[3] Axicabtagene-ciloleucel/brexucabtagene-autoleucel/tisagenlecleucelMultiple toxicities: 12 case reports
Reactions Weekly, 2022, 1932 (1) : 115 - 115
[4] Axicabtagene-ciloleucel/nivolumabLack of efficacy: 7 case reports
Reactions Weekly, 2023, 1974 (1) : 68 - 68
[5] Ipilimumab/nivolumabVarious toxicities: 2 case reports
Reactions Weekly, 2022, 1913 (1) : 265 - 265
[6] Ipilimumab/nivolumabVarious toxicities: 2 case reports
Reactions Weekly, 2020, 1811 (1) : 160 - 160
[7] Ipilimumab/nivolumabVarious toxicities: 2 case reports
Reactions Weekly, 2022, 1936 (1) : 274 - 274
[8] Ipilimumab/nivolumabVarious toxicities: 2 case reports
Reactions Weekly, 2019, 1771 (1) : 180 - 180
[9] Ipilimumab/nivolumabVarious toxicities: 2 case reports
Reactions Weekly, 2020, 1790 (1) : 141 - 141
[10] Ipilimumab/nivolumabVarious toxicities: 2 case reports
Reactions Weekly, 2017, 1676 (1) : 175 - 175

← 1 2 3 4 5 →